ALVO:NASDAQ, Alvotech

ALVO stock overview

Alvotech (ALVO:NASDAQ) closed at $4.62 on October 26, 2026, up 0.87% on the day. The stock trades 45.6% below its 52-week high of $8.50 and 57.1% above its 52-week low of $2.94. Over the past year, it lost 43.2%. Alvotech is part of the Health Care sector.

Key figures

Price
$4.62
Day change
+0.87%
Volume
584,879
Average volume
1,090,358
Market cap
1B+
52-week range
$2.94 – $8.50
50-day average
$5.25
200-day average
$4.21

Price action over the past year

In 252 trading sessions since October 24, 2025, ALVO closed higher on 120 days (48%). Its best day was June 8, 2026 (+19.77%) and its worst was November 3, 2025 (-34.25%). The stock moved 10% or more in a single session 11 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

ALVO news

About Alvotech

Alvotech is a integrated biopharmaceutical company committed to developing and manufacturing high quality biosimilar medicines for patients globally. The company's purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Similar stocks

Find more stocks like ALVO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.